Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.
Align Technology, Inc. (NASDAQ: ALGN) is a global medical device company best known for the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software. The ALGN news feed on Stock Titan aggregates company announcements, clinical product updates, financial disclosures, and professional education highlights directly relevant to investors and dental professionals.
Recent news shows Align focusing on digital orthodontics and restorative dentistry, with updates on innovations such as ClinCheck® Live Plan for automated Invisalign treatment planning, new features for iTero Digital Solutions, and expanded availability of Invisalign System options like mandibular advancement with occlusal blocks for Class II correction in growing patients. News items also cover Align’s participation in major dental congresses, including the Greater New York Dental Meeting, where the company showcases its Align™ Digital Platform and related tools.
Investors following ALGN news will see regular earnings announcements and outlook updates, including quarterly revenue, clear aligner volumes, imaging systems and CAD/CAM services performance, and commentary on geographic trends. SEC-related press releases, such as those tied to Form 8-K filings on financial results or leadership changes, also appear in the news flow.
Align’s communications further highlight research, education, and community programs, including its Annual Research Award Program for university-based dental research and partnerships with organizations like the Canadian Foundation for the Advancement of Orthodontics through Smiles4Canada. For users tracking ALGN, this news page offers a centralized view of product launches, clinical innovations, financial milestones, and corporate initiatives that shape the company’s role in digital dentistry.
Align Technology (Nasdaq: ALGN) reported Q4'25 record total revenue of $1,047.6M, up 5.2% sequentially and 5.3% year-over-year, and record Q4 clear aligner shipments of 676.9K cases. FY2025 revenue was a record $4.035B, clear aligner revenue $3.245B, and clear aligner shipments 2.611M.
Q4 GAAP net income was $135.8M ($1.89 diluted EPS); non-GAAP net income was $236.0M ($3.29 diluted EPS). Company repurchased 2.9M shares in 2025 and expects 2026 revenue growth of 3%–4%.
Align Technology (NASDAQ: ALGN) is collaborating with the University of Bern on Switzerland’s first large-scale Swiss Oral Health Study, launched August 2025. The study will scan approximately 1,800 children by June 2026 and 1,650 adults by end-2027 across six cantons.
Align is supplying the iTero Lumina intraoral scanner and an Align-branded mobile dental van to enable on-site digital scans, NIRI imaging and longitudinal data collection to improve diagnostic accuracy and public-health planning.
Align Technology (NASDAQ: ALGN) announced on January 13, 2026 that it will sponsor 30 Invisalign treatments through the Canadian Foundation for the Advancement of Orthodontics (CFAO) Smiles4Canada program to help children and teens with significant orthodontic needs whose families lack financial resources.
The company said the support builds on its global charitable programs, noting Smiles4Canada has helped more than 800 children to date and Align’s ARK program has waived lab fees for over 200 patients since 2019. Align highlighted discounted-fee and donation programs across Canada, the US, EMEA and Australia to expand access to Invisalign care.
Align Technology (Nasdaq: ALGN) will report Q4 and full-year 2025 results on Wednesday, February 4, 2026 after market close. Financial results will be released at 4:00 p.m. ET and a conference call will follow at 4:30 p.m. ET, available via live audio webcast on the company Investor Relations site. An archived webcast will be posted about two hours after the call and remain available for one month.
Align also published anticipated 2026 quarterly earnings dates (Q1'26 Apr 29; Q2'26 Jul 29; Q3'26 Oct 28; Q4'26 Feb 3, 2027) and reiterated operating scope: ~291.0 thousand doctor customers, ~21.4 million patients treated, and a 600 million consumer market opportunity.
Align Technology (Nasdaq: ALGN) announced commercial availability of the Invisalign System with mandibular advancement featuring occlusal blocks in Thailand and across multiple APAC markets. The product is Align’s first clear aligner with integrated solid occlusal blocks designed to deliver predictable mandibular advancement while simultaneously aligning teeth for growing patients in the late mixed to early permanent dentition (ages 10–16).
Key features include solid laser‑welded occlusal blocks for durability and vertical opening, earlier mandibular advancement for deep‑bite cases, SmartTrack™ material for comfort, allowance of attachments under blocks, and regional commercial availability in Australia, New Zealand, Japan, Hong Kong, Malaysia, Singapore, India, Korea, China, Vietnam, Philippines and Thailand.
Align Technology (NASDAQ: ALGN) highlighted its Align Digital Platform innovations at the Greater New York Dental Meeting 2025 on December 3, 2025, showcasing hardware, software, and clinical education for dental professionals.
Key demos included the iTero Lumina scanner with Multi-Direct Capture and larger field of view, Invisalign Smile Architect with Multiple Treatment Plans, ClinCheck Signature global rollout, iTero Design Suite for in-practice 3D printing, Align Oral Health Suite, and exocad DentalCAD 3.3 Chemnitz with upgraded Implant Module and AI-enabled multi-unit design.
Align Technology (Nasdaq: ALGN) was named Most Honored Company in Extel Insights' 2025 All-America Executive Team rankings and earned multiple #1, #3 and top-10 placements across leadership, board, investor relations, and investor/analyst event categories.
Key recognitions included Best CEO Joseph Hogan (#1 Large-Cap, #3 sector), Best CFO John Morici (#1 Large-Cap, #3 sector), Best Company Board (#1 Large-Cap), and top rankings for the IR program, IR team, IR professionals, and investor/analyst event. The awards mark Align's third Extel recognition in four years.
Align Technology (Nasdaq: ALGN) announced commercial availability on November 25, 2025 of the Invisalign System with mandibular advancement featuring occlusal blocks for growing patients.
The product targets ages 10–16, combines mandibular advancement with tooth alignment in one appliance, uses solid laser‑welded occlusal blocks and SmartTrack™ material for durability and comfort, and enables earlier mandibular advancement in deep‑bite Class II cases. Initial commercial rollout covers multiple APAC markets including the Philippines, Australia, Japan, China, India and others.
Align Technology (Nasdaq: ALGN) will present at four upcoming financial conferences in November–December 2025: UBS Global Healthcare (Nov 11), Jefferies Healthcare (Nov 18), Piper Sandler Healthcare (Dec 2), and Evercore Healthcare (Dec 3). Senior executives scheduled to speak include Joe Hogan (President & CEO), John Morici (EVP Global Finance and CFO), and other senior finance and investor relations leaders.
All presentations will be webcast live via the Investor Relations site at http://investor.aligntech.com, with archived replays available on the site for approximately one month.
Align Technology (NASDAQ: ALGN) opened its 2026 Annual Research Award Program offering up to $300,000 in total funding to support clinical and scientific dental research at universities worldwide. Individual regional awards include four one-year grants up to $25,000 each for Americas, EMEA, and APAC. The program has funded approximately $3.96 million since 2010. Applications are due by 5:00 p.m. PT on March 6, 2026, and awardees will be notified by June 1, 2026.
Eligible applicants are university faculty where Invisalign or iTero is available; selections follow independent academic review and Align’s final decision.